Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists".
Loading...
Issue Date
2024-02
Authors
Hong, Lisa T
Downes, Kevin J
FakhriRavari, Alireza
Abdul-Mutakabbir, Jacinda C
Kuti, Joseph L
Jorgensen, Sarah
Young, David C
Alshaer, Mohammad H
Bassetti, Matteo
Bonomo, Robert A
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
Citation
Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, Young DC, Alshaer MH, Bassetti M, Bonomo RA, Gilchrist M, Jang SM, Lodise T, Roberts JA, Tängdén T, Zuppa A, Scheetz MH. Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists". Pharmacotherapy. 2024 Feb;44(2):208-209. doi: 10.1002/phar.2907. PMID: 38362632.
ACPHS Research Commons URI
Description
Click on the Resource Link to access the article (may not be free).